Pb212

1 stories · following the connections

Business

RadioMedix and AREVA Med – SBIR NCI Contract Grant awarded to develop targeted alpha-emitter therapy of neuroendocrine tumors with lead-212

By Nasdaq OMXNov 1, 2016, 5:00 AM UTC